RLLVF (Relevium Technologies) DeferredTaxAndRevenue: $0.82 Mil (As of Mar. 2022)


What is Relevium Technologies DeferredTaxAndRevenue?

Relevium Technologies RLLVF -99.98% DeferredTaxAndRevenue is $0.82 Mil as of Mar. 2022.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Relevium Technologies's current deferred tax and revenue for the quarter that ended in Mar. 2022 was $0.82 Mil.

Relevium Technologies DeferredTaxAndRevenue Related Terms


Relevium Technologies DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Relevium Technologies's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Relevium Technologies DeferredTaxAndRevenue Chart

Relevium Technologies Annual Data
Trend Dec12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.84

Relevium Technologies Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.01 0.84 0.00 0.00 0.82
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.82 Mil mean?
Relevium Technologies (RLLVF) has a DeferredTaxAndRevenue of $0.82 Mil as of Mar. 2022. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Relevium Technologies.
Is Relevium Technologies' DeferredTaxAndRevenue too high?
Relevium Technologies' current DeferredTaxAndRevenue is $0.82 Mil.
How does Relevium Technologies' DeferredTaxAndRevenue compare to HEWA and SSY?
Relevium Technologies' DeferredTaxAndRevenue of $0.82 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Healthcare Providers & Services company?
A good DeferredTaxAndRevenue depends on the Healthcare Providers & Services industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Relevium Technologies. Relevium Technologies's current DeferredTaxAndRevenue is $0.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Relevium Technologies stock overvalued right now?
Relevium Technologies (RLLVF) has a current DeferredTaxAndRevenue of $0.82 Mil. The current DeferredTaxAndRevenue is $0.82 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Relevium Technologies (RLLVF), the current DeferredTaxAndRevenue is $0.82 Mil as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Relevium Technologies Business Description

Address 1000 Sherbrooke Street West, Suite 2700, Montreal, QC, CAN, H3A 3G4
Relevium Technologies Inc is a Canada based company operates in the health and wellness industry with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition, and operations of brands and businesses in the health and wellness markets including medical cannabis. Its operating segment includes Consumer Packaged Goods (CPG); Pediatric Biopharma and Corporate. The company generates maximum revenue from Consumer Packaged Goods segment.